These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection. Bradbury F. J Antimicrob Chemother; 1993 Jun; 31 Suppl E():153-62. PubMed ID: 8396087 [Abstract] [Full Text] [Related]
3. Efficacy of a three day course of azithromycin in moderately severe community-acquired pneumonia. Rizzato G, Montemurro L, Fraioli P, Montanari G, Fanti D, Pozzoli R, Magliano E. Eur Respir J; 1995 Mar; 8(3):398-402. PubMed ID: 7789484 [Abstract] [Full Text] [Related]
4. Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia. Kinasewitz G, Wood RG. Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):872-7. PubMed ID: 1662636 [Abstract] [Full Text] [Related]
5. Multicentre comparison of azithromycin versus erythromycin in the treatment of paediatric pharyngitis or tonsillitis caused by group A streptococci. Weippl G. J Antimicrob Chemother; 1993 Jun; 31 Suppl E():95-101. PubMed ID: 8396103 [Abstract] [Full Text] [Related]
6. Comparison of three-day and five-day courses of azithromycin in the treatment of atypical pneumonia. Schönwald S, Skerk V, Petricevic I, Car V, Majerus-Misic L, Gunjaca M. Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):877-80. PubMed ID: 1662637 [Abstract] [Full Text] [Related]
7. Simplified treatment of acute lower respiratory tract infection with azithromycin: a comparison with erythromycin and amoxycillin. European Azithromycin Study Group. Daniel R. J Int Med Res; 1991 Oct; 19(5):373-83. PubMed ID: 1660824 [Abstract] [Full Text] [Related]
9. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children. Kogan R, Martínez MA, Rubilar L, Payá E, Quevedo I, Puppo H, Girardi G, Castro-Rodriguez JA. Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069 [Abstract] [Full Text] [Related]
10. Clinical comparative study of azithromycin versus erythromycin in the treatment of acute respiratory tract infections in children. Manfredi R, Jannuzzi C, Mantero E, Longo L, Schiavone R, Tempesta A, Pavesio D, Pecco P, Chiodo F. J Chemother; 1992 Dec; 4(6):364-70. PubMed ID: 1337553 [Abstract] [Full Text] [Related]
11. Contradiction between in vitro and clinical outcome: intravenous followed by oral azithromycin therapy demonstrated clinical efficacy in macrolide-resistant pneumococcal pneumonia. Kohno S, Tateda K, Kadota J, Fujita J, Niki Y, Watanabe A, Nagashima M. J Infect Chemother; 2014 Mar; 20(3):199-207. PubMed ID: 24477328 [Abstract] [Full Text] [Related]
16. Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study. Tamm M, Todisco T, Feldman C, Garbino J, Blasi F, Hogan P, de Caprariis PJ, Hoepelman IM. Clin Microbiol Infect; 2007 Feb; 13(2):162-171. PubMed ID: 17328728 [Abstract] [Full Text] [Related]
19. Comparison of azithromycin and erythromycin in the treatment of atypical pneumonias. Schönwald S, Gunjaca M, Kolacny-Babić L, Car V, Gosev M. J Antimicrob Chemother; 1990 Jan; 25 Suppl A():123-6. PubMed ID: 2154431 [Abstract] [Full Text] [Related]
20. Efficacy and safety of azithromycin 1 g once daily for 3 days in the treatment of community-acquired pneumonia: an open-label randomised comparison with amoxicillin-clavulanate 875/125 mg twice daily for 7 days. Paris R, Confalonieri M, Dal Negro R, Ligia GP, Mos L, Todisco T, Rastelli V, Perna G, Cepparulo M. J Chemother; 2008 Feb; 20(1):77-86. PubMed ID: 18343748 [Abstract] [Full Text] [Related] Page: [Next] [New Search]